Subtemporalis Muscle Middle Cranial Fossa Bone-Island Craniotomy Technique for Placement of an Active Transcutaneous Bone-Conduction Implant.
Journal
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504
Informations de publication
Date de publication:
01 01 2023
01 01 2023
Historique:
entrez:
12
12
2022
pubmed:
13
12
2022
medline:
15
12
2022
Statut:
ppublish
Résumé
Placement of an active transcutaneous bone-conduction implant (BCI) requires drilling of a precise bone bed to accommodate the device and allow for fixation points to make appropriate contact with bone, which can be difficult even when lifts are used. We describe a subtemporalis muscle middle cranial fossa bone-island craniotomy technique that simplifies the procedure and obviates the need for lifts in securing the device. Prospective case series. Tertiary academic medical center. Seventeen patients underwent surgery for placement of 18 transcutaneous BCIs, 14 for conductive or mixed hearing loss, and 4 for single-sided deafness. Surgical placement of a transcutaneous BCI with a bone-island craniotomy technique. Functional gain in air-conduction thresholds, aided air-bone gap, frequency of need for lifts, and minor and major complications. For the conductive or mixed hearing loss cohort, with the transcutaneous BCI in place, there was a highly statistically significant mean functional gain of 35.4 dB hearing level (HL) (range, 16.7-50.25 dB HL; standard deviation, 12.4 dB HL) compared with the unaided condition (p < 0.0001; 95% confidence interval, 36.6-51.6 dB HL). Lifts were not needed in any case. There was one minor complication requiring a second procedure in a patient who had previously received radiation and no major complications. There was no device loss or failure. A subtemporalis muscle middle cranial fossa bone-island craniotomy technique eliminates the need for lifts and is a safe and effective method for placement of a transcutaneous BCI.
Identifiants
pubmed: 36509440
doi: 10.1097/MAO.0000000000003760
pii: 00129492-202301000-00014
pmc: PMC9762702
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
54-60Informations de copyright
Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of Otology & Neurotology, Inc.
Déclaration de conflit d'intérêts
The authors disclose no conflicts of interest and no sources of funding.
Références
Florentine MM, Virbalas J, Chan DK. Early surgical and audiologic outcomes of active, transcutaneous, osseointegrated bone-conduction hearing device (Osia 2® system) placement. Int J Pediatr Otorhinolaryngol 2022;156:111114.
Bae SH, Jung Y, Jung J, et al. Clinical experience of using active transcutaneous bone conduction implants (BONEBRIDGE) in children under 5 years old. Clin Exp Otorhinolaryngol 2022;15:194–6.
Cywka KB, Skarżyński H, Król B, et al. The BONEBRIDGE BCI 602 active transcutaneous bone-conduction implant in children: Objective and subjective benefits. J Clin Med 2021;10:5916.
Gordon KA, Papsin BC, Feness M, et al. First generation osseointegrated steady state implant benefits in children with hearing loss. Otol Neurotol 2022;43:337–44.
You P, Choy DJ, Drob J, et al. Early outcomes of a new active transcutaneous bone conduction implant in pediatric atients. Otol Neurotol 2022;43:212–8.
Lustig LR, Arts HA, Brackmann DE, et al. Hearing rehabilitation using the bone anchored hearing aid (BAHA): The United States experience. Otol Neurotol 2001;22:328–34.
Ellsperman SE, Nairn EM, Stucken EZ. Review of bone conduction hearing devices. Audiol Res 2021;11:207–19.
Ontario Health (Quality). Implantable devices for single-sided deafness and conductive or mixed hearing loss: A health technology assessment. Ont Health Technol Assess Ser 2020;20:1–165.
Oberlies NR, Castaño JE, Freiser ME, et al. Outcomes of BAHA connect vs BAHA attract in pediatric patients. Int J Pediatr Otorhinolaryngol 2020;135:110125.
Rahne T, Plontke SK. Systematic and audiological indication criteria for bone-conduction devices and active middle ear implants. Hear Res 2021;25:108424.
Reinfeldt S, Håkansson B, Taghavi H, et al. New developments in bone-conduction hearing implants: A review. Med Devices (Auckl) 2015;8:79–93.
Niparko JK, Cox KM, Lustig LR. Comparison of the bone anchored hearing aid implantable hearing device with contralateral routing of offside signal amplification in the rehabilitation of unilateral deafness. Otol Neurotol 2003;24:73–8.
Desmet J, Wouters K, De Bodt M, et al. Long-term subjective benefit with a bone-conduction implant sound processor in 44 patients with single-sided deafness. Otol Neurotol 2014;35:1017–25.
Huber AM, Strauchmann B, Caversaccio MD, et al. Multicenter results with an active transcutaneous bone-conduction implant in patients with single-sided deafness. Otol Neurotol 2022;43:227–35.
Sprinzl GM, Wolf-Magele A. The BONEBRIDGE bone-conduction hearing implant: iIndication criteria, surgery and a systematic review of the literature. Clin Otolaryngol 2016;41:131–43.
Gerdes T, Salcher RB, Schwab B, Lenarz T, Maier H. Comparison of audiological results between a transcutaneous and a percutaneous bone-conduction instrument in conductive hearing loss. Otol Neurotol 2016;37:685–91.
BONEBRIDGE (BCI 602) Surgical Guide, MED-EL GmbH. Version: AW52713_R2.0 (English US), 2019.
Zernotti ME, Sarasty AB. Active bone conduction prosthesis: BONEBRIDGE(TM). Int Arch Otorhinolaryngol 2015;19:343–8.
Carnevale C, Tomás-Barberán M, Til-Pérez G, et al. The BONEBRIDGE active bone-conduction system: A fast and safe technique for a middle fossa approach. J Laryngol Otol 2019;133:344–7.
You P, Siegel LH, Kassam Z, et al. The middle fossa approach with self-drilling screws: A novel technique for BONEBRIDGE implantation. J Otolaryngol Head Neck Surg 2019;48:35.
Plontke SK, Radetzki F, Seiwerth I, et al. Individual computer-assisted 3D planning for surgical placement of a new bone-conduction hearing device. Otol Neurotol 2014;35:1251–7.
Siegel L, You P, Zimmerman K, Parnes L, Agrawal SK. Active transcutaneous bone-conduction implant: Audiometric outcomes following a novel middle fossa approach with self-drilling screws. Otol Neurotol 2020;41:605–13.
Gurgel RK, Oghalai JS, Chang KW, et al. Correlation of measured vs averaged 3 kHz pure tone averages. Otolaryngol Head Neck Surg 2011;145(2_suppl):P90. doi:10.1177/0194599811416318a156.
doi: 10.1177/0194599811416318a156
Gatehouse S, Noble W. The Speech, Spatial and Qualities of Hearing Scale (SSQ). Int J Audiol 2004;43:85–99.
Ihler F, Volbers L, Blum J, et al. Preliminary functional results and quality of life after implantation of a new bone-conduction hearing device in patients with conductive and mixed hearing loss. Otol Neurotol 2014;35:211–5.
Manrique M, Sanhueza I, Manrique R, et al. A new bone-conduction implant: Surgical technique and results. Otol Neurotol 2014;35:216–20.
Schmerber S, Deguine O, Marx M, et al. Safety and effectiveness of the Bonebridge transcutaneous active direct-drive bone-conduction hearing implant at 1-year device use. Eur Arch Otorhinolaryngol 2017;274:1835–51.